SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹50 Cr | ₹56 Cr | ₹53 Cr | ₹37 Cr | ₹27 Cr |
What is the latest Total Current Liabilities ratio of SAMRAT PHARMACHEM ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹53 Cr |
| Mar2022 | ₹37 Cr |
| Mar2021 | ₹27 Cr |
How is Total Current Liabilities of SAMRAT PHARMACHEM Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | -12.09 | |
| Mar2024 | ₹56 Cr | 6.04 | |
| Mar2023 | ₹53 Cr | 42.49 | |
| Mar2022 | ₹37 Cr | 36.60 | |
| Mar2021 | ₹27 Cr | - | |
Compare Total Current Liabilities of peers of SAMRAT PHARMACHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAMRAT PHARMACHEM | ₹63.8 Cr | -12.1% | -3.6% | -37.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
SAMRAT PHARMACHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAMRAT PHARMACHEM | -12.1% |
-3.6% |
-37.8% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses